ISO 21474-2

PECB Store

View profile

ISO 21474-2:2022

(0 customer reviews)


ISO 21474-2:2022 In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 2: Validation and verification

*Taxes or charges may apply. The final price, including any applicable taxes, will be calculated at checkout.

USD 106.00

This document gives the general requirements for validation and verification of multiplex molecular tests which simultaneously identify two or more nucleic acid target sequences of interest. This document is applicable to all multiplex methods used for examination using IVD medical devices and laboratory developed tests (LDTs). It provides information for both qualitative and quantitative detection of nucleic acid target sequences.

This document is intended as guidance for multiplex examinations that either detect and/or quantify human nucleic acid target sequences or microbial pathogen nucleic acid target sequences from human clinical specimens.

This document is applicable to any molecular in vitro diagnostic (IVD) examination performed by medical laboratories. It is also intended to be used by laboratory customers, IVD developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research and regulatory authorities. This document is not applicable to metagenomics.

NOTE       An examination procedure developed for a laboratory’s own use is often referred to as a “laboratory developed test,” “LDT,” or “in-house test”.

Standard Number ISO 21474-2:2022
Title ISO 21474-2:2022 In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 2: Validation and verification
Status Published
Publication Date 13 May 2022
Committee ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems
Publisher PECB Store
Format PDF
Pages 15
Price USD 106.00
There are no reviews for this product yet

PECB Store

View profile